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Spotlight On Summer Research and Creativity Grants

Fei Xiong

Investigating a Conformational
Change in the Enzyme Neurolysin
		 This summer I am working with Dr.
David Rodgers in the Department of
Molecular and Cellular Biochemistry at
the University of Kentucky. I continue to
investigate a proposed conformational change in the enzyme
neurolysin, a zinc metallopeptidase that regulates peptide
signaling molecules. My previous studies provided evidence
that the enzyme undergoes a hinge-like motion during catalysis
and demonstrated the ability of a novel inhibitor to interfere
with that motion. I have expanded my work with neurolysin
this summer using mutagenesis techniques to further
investigate the conformational changes and the mechanism
of inhibition. This gave me my first practical experience with
molecular biology and genetics techniques. Dr. Rodgers and
I have worked closely together for more than a year, and we
discuss the project on a daily basis.
My goal for this summer is to use site-directed
mutagenesis to alter the charge on the inner channel walls of
the channel in neurolysin as well as to modify the binding
site for the inhibitor C28. Since the channel walls have an
overall negative surface charge, we hypothesize that increasing
the charge will bias the enzyme toward an open conformation,
which should reduce the activity of the enzyme. Furthermore,
we hypothesize that C28 acts by inhibiting the hinge motion
and that we can mimic this effect by using mutagenesis to fill
the normal binding site of the inhibitor.

Progress
To begin my work, Dr. Rodgers and I used the crystal
structure of neurolysin to find modifiable sites on the protein
so as to change the surface charge, settling on the mutation
of lysine 221 and arginine 248 to glutamate residues. We
then designed oligonucleotide primers that could be used
in site-directed mutagenesis to make the mutations and had
the primers synthesized commercially. While waiting for
the primers, I learned how to transform bacteria with the
expression plasmid for neurolysin, and then I used a miniprep
kit to make a stock of plasmid DNA. We then used the primers
and plasmid DNA with the QuikChange mutagenesis system
(Stratagene) to introduce the mutations by polymerase chain
reaction (PCR) amplification.
We had a hard time making mutations on the wall surface
of the enzyme at first. Because the mutagenesis protocol has
been known to work properly, we had to sequentially eliminate
possible causes of failure. The problem was eventually solved
by repeating the protocol using freshly ordered reagents and
by making fresh agar plates and media. Soon after solving the

buffer problem, we realized that something was amiss with
the cell stock, possibly mutations or damage due to long term
storage. Whatever it was, the cell stock was newly cultured
and all problems have been overcome. We believe we have
introduced the mutations successfully, and we are awaiting final
sequencing conformation. In the meantime we are proceeding
with attempts to overexpress and purify the mutant proteins,
and we are designing primers to introduce the mutations at
the C28 binding site.

Future Plans
Assuming we have introduced the mutations correctly,
we will then overexpress and purify the mutant enzymes
according to well-established protocols in the group. The
kinetic parameters of the wild type and mutant neurolysin
constructs will then be determined by using fluorogenic
peptide substrates (neurotensin and dynorphin A(1-8)). The
conformational state of the mutant enzymes will also be
determined by measuring rotational tumbling times using
fluorescence polarization anisotropy measurements, and these
will be compared to data for the wild type enzyme.
In parallel, we will mutate serine 146, leucine 69, and
valine 119 to tryptophan residues in order to fill the C28
binding site. The idea is to increase the sizes of these amino
acids to fill the C28 binding to mimic the inhibitor-bound
state. We hypothesize C28 inhibits by stabilizing the open,
inactive conformation of the enzyme and that filling the
binding site should have the same effect. The expected result is
that the mutated neurolysin would lose a significant amount
of activity. I will also use fluorescence polarization to monitor
the conformational changes of the altered enzymes and
characterize the kinetic properties of the mutants on several
substrates.
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